rdf:type |
|
lifeskim:mentions |
|
pubmed:issue |
3
|
pubmed:dateCreated |
2010-5-24
|
pubmed:abstractText |
To describe the biochemical failure-free survival (BFFS), GU toxicity and erectile dysfunction in intermediate risk prostate cancer treated with iodine 125 monotherapy (I125).
|
pubmed:language |
fre
|
pubmed:journal |
|
pubmed:citationSubset |
IM
|
pubmed:chemical |
|
pubmed:status |
MEDLINE
|
pubmed:month |
Jun
|
pubmed:issn |
1769-6658
|
pubmed:author |
|
pubmed:copyrightInfo |
2010 Société française de radiothérapie oncologique (SFRO). Published by Elsevier SAS. All rights reserved.
|
pubmed:issnType |
Electronic
|
pubmed:volume |
14
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
183-8
|
pubmed:meshHeading |
pubmed-meshheading:20418145-Adenocarcinoma,
pubmed-meshheading:20418145-Aged,
pubmed-meshheading:20418145-Antineoplastic Agents, Hormonal,
pubmed-meshheading:20418145-Brachytherapy,
pubmed-meshheading:20418145-Combined Modality Therapy,
pubmed-meshheading:20418145-Disease-Free Survival,
pubmed-meshheading:20418145-Erectile Dysfunction,
pubmed-meshheading:20418145-Follow-Up Studies,
pubmed-meshheading:20418145-Humans,
pubmed-meshheading:20418145-Iodine Radioisotopes,
pubmed-meshheading:20418145-Male,
pubmed-meshheading:20418145-Middle Aged,
pubmed-meshheading:20418145-Prostate-Specific Antigen,
pubmed-meshheading:20418145-Prostatic Neoplasms,
pubmed-meshheading:20418145-Quebec,
pubmed-meshheading:20418145-Radiation Injuries,
pubmed-meshheading:20418145-Retrospective Studies,
pubmed-meshheading:20418145-Risk,
pubmed-meshheading:20418145-Treatment Outcome,
pubmed-meshheading:20418145-Urination Disorders
|
pubmed:year |
2010
|
pubmed:articleTitle |
[Clinical outcome of intermediate risk prostate cancer treated with iodine 125 monotherapy: The Hotel-Dieu of Quebec experience].
|
pubmed:affiliation |
Département de radiothérapie, CHUQ Hôtel-Dieu, Côte-du-Palais, QC, Canada.
|
pubmed:publicationType |
Journal Article,
English Abstract,
Evaluation Studies
|